Montreal / August 28, 2018 / TheNewswire / DMD Digital Health Connections Group Inc. ("DMD") (NEX: DMG.H) and 10653365 Canada Inc are pleased to announce that subsequent to receiving an interim order (the “Interim Order”) from the Superior Court of Québec in connection with the proposed arrangement (the “Arrangement”) announced on August 22, 2018, the information circular for the annual and special meeting of DMD’s shareholders was posted today on SEDAR.

 

In connection with the meeting, shareholders will receive by mail the circular, together with the letter of transmittal, the related proxy materials and a notice of presentation of motion for final order by the Superior Court of Québec along with its answer form.

 

Shareholder Questions

Voting is simple. Due to the essence of time shareholders are encouraged to vote today using the internet, telephone or facsimile. Shareholders may contact DMD's solicitation agent, Laurel Hill Advisory for voting assistance or if there are questions relating to the Meeting.

Laurel Hill Advisory Group

North America Toll Free: 1-877-452-7184

Collect Calls Outside North America: 1-416-304-0211

Email: assistance@laurelhill.com

About DMD Digital Health Connections Group Inc. (“DMD”)

DMD enables pharmaceutical, pharmaceutical marketing companies, digital advertising agencies and medical device companies to reach, message, connect and interact with US physicians and healthcare professionals via multiple access channels. Its service offerings provide targeted impressions and interactions through permission-based email, targeted on-line ad-serving, and mobile app advertising channels. Several pharmaceutical companies, agencies and healthcare organizations have adopted DMD's solutions to target, engage and interact with healthcare practitioners. For more information, visit www.dmdconnects.com.

Neither NEX platform of the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.